Showing results (1-10 of 434) with videos related to
Sort By:
Pageof 44
Journal of Oncology Practice|April 14, 2016
Myeloma Is Not a Single DiseaseSagar Lonial, Ajay K NookaCancer Journal (Sudbury, Mass.)|January 30, 2019
Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple MyelomaAjay K Nooka, Sagar LonialOncology (Williston Park, N.Y.)|May 19, 2016
Novel Combination Treatments in Multiple MyelomaAjay K Nooka, Sagar LonialAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
New Targets and New Agents in High-Risk Multiple MyelomaAjay K Nooka, Sagar LonialClinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Is Maintenance Therapy for Everyone?Ajay K Nooka, Sagar LonialCancer|August 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myelomaAjay K Nooka, Nisha S Joseph, Sagar LonialBlood|April 4, 2015
Treatment options for relapsed and refractory multiple myelomaAjay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.Blood Advances|January 4, 2018
TG02 inhibits proteasome inhibitor-induced HSF1 serine 326 phosphorylation and heat shock response in multiple myelomaShardule P Shah, Ajay K Nooka, Sagar Lonial, et al.Future Oncology (London, England)|August 24, 2018
Daratumumab and its use in the treatment of relapsed and/or refractory multiple myelomaSarah Chehab, Elyse Hall Panjic, Charise Gleason, et al.Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
High-risk Multiple Myeloma: Definition and ManagementNisha S Joseph, Silvia Gentili, Jonathan L Kaufman, et al.Pageof 44